Daniel Garen is a healthcare compliance and technology lawyer who develops and helps implement best-in-class compliance and risk management strategies at public and private pharmaceutical, biotechnology, medical device, and technology companies around the world. He uses quantitative analysis and process optimization to counsel clients on mitigating risk and streamlining business workflows. Daniel utilizes a continuous improvement suite of tools to deploy compliance as a business accelerator. 

Daniel has led the resolution efforts for multi-jurisdictional deferred prosecution agreements, corporate integrity agreements, corporate raids, and civil investigative demands. He provides strategic advice to management teams and boards on the use of data visualization and statistical analysis to understand complex legal matters. 

Daniel was previously the head of clinical affairs for a Fortune 100 company and brings a deep understanding of clinical collaborations with academic institutions. He also advises commercial and research organizations on product launch strategies based on market intelligence and approved labelling. Further, he has served as chief compliance officer for several large and medium cap multinational organizations.